Medical Center for Specialized Care for Cardiovascular Diseases EAD

At the Medical Center for Specialized Care for Cardiovascular Diseases EAD in Sofia, much of the research focuses on cardiovascular disease and related risk conditions. The trials are designed to better prevent serious events, improve heart failure care, and test new approaches for managing cholesterol, triglycerides, and blood pressure.

• Studies in atherosclerotic cardiovascular disease and high-risk patients aim to reduce heart attack, stroke, and other major complications.
• Research in heart failure, including reduced and preserved ejection fraction, is evaluating treatments that may improve symptoms and outcomes.
• Trials in hypertriglyceridemia are testing whether new therapies can lower triglyceride levels and address severe lipid disorders.
• Some projects assess whether better control of hypertension and overall cardiovascular risk can prevent future events.

Overall, this site is active in studies that combine prevention and treatment goals, with a strong emphasis on improving care for people at elevated cardiovascular risk.

Another important area of research at this site is nutritional and metabolic disease, especially conditions linked to abnormal blood fats and cardiometabolic risk. These trials are exploring new ways to lower triglycerides, improve lipid control, and support patients whose current treatment is not enough.

• Research in severe hypertriglyceridemia is focused on testing therapies that may bring triglyceride levels down more effectively.
• Studies in hyperlipidemia and atherosclerosis are looking at whether improved lipid management can reduce long-term vascular risk.
• Trials involving type 2 diabetes and cardiovascular disease are examining combined approaches to lower heart-related complications.
• Some studies evaluate whether new treatments can improve the balance between metabolic control and cardiovascular protection.

This research reflects a broader effort to connect metabolic health with heart and blood vessel outcomes in everyday clinical care.

Heart failure is a major focus at this health care site, with trials examining both symptom relief and prevention of worsening disease. The studies include patients with chronic heart failure, HFpEF, and HFrEF, showing a broad interest in improving care across different forms of the condition.

• Several trials are testing whether new therapies can reduce hospitalization for heart failure and urgent care visits.
• Research is also assessing changes in biomarkers such as NT-proBNP as a way to measure treatment benefit.
• Some studies look at combination approaches for people with heart failure and additional conditions such as type 2 diabetes or hypertension.
• One area of interest is whether correcting iron deficiency can improve outcomes in symptomatic heart failure.

These trials aim to strengthen treatment options for patients living with chronic heart failure and to reduce the burden of repeated cardiac events.

Beyond cardiovascular research, the site also contributes to studies in musculoskeletal disease, especially inflammatory conditions in children and adolescents. These trials focus on juvenile psoriatic arthritis and polyarticular-course juvenile idiopathic arthritis, where the goal is to improve disease control and daily functioning.

• Research in juvenile psoriatic arthritis is evaluating whether newer treatments can better manage symptoms in young patients.
• Studies in juvenile idiopathic arthritis are looking at safety, tolerability, and effectiveness in pediatric populations.
• These trials aim to support better long-term control of inflammatory joint disease in children and teenagers.
• The work adds an important pediatric dimension to the site’s broader clinical research portfolio.

By including both cardiovascular and pediatric inflammatory research, the Medical Center for Specialized Care for Cardiovascular Diseases EAD shows a diverse trial profile with a strong clinical focus.